Trace amounts of mefenamic acid may be present in breast milk and transmitted to nursing infant; because of potential for serious adverse reactions in nursing
Mefenamic acid was approved in the United States in 1967, but is not a commonly used agent
Mefenamic acid is an aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3
Zinc(II) complexes of a non-steroidal anti-inflammatory drug, mefenamic acid(=Hmef) in the absence or presence of the nitrogen donor heterocyclic